CLINICAL TRIALS PROFILE FOR CLINORIL

All Clinical Trials for CLINORIL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00005882 ↗	Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps	Completed	Chao Family Comprehensive Cancer Center	Phase 3	1998-07-01	This randomized phase III trial is studying eflornithine and sulindac to see how well they work compared to a placebo in preventing colorectal cancer in patients with colon polyps. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of eflornithine and sulindac may prevent colorectal cancer. It is not yet known whether eflornithine and sulindac are more effective than a placebo in preventing colorectal cancer
NCT00005882 ↗	Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps	Completed	National Cancer Institute (NCI)	Phase 3	1998-07-01	This randomized phase III trial is studying eflornithine and sulindac to see how well they work compared to a placebo in preventing colorectal cancer in patients with colon polyps. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of eflornithine and sulindac may prevent colorectal cancer. It is not yet known whether eflornithine and sulindac are more effective than a placebo in preventing colorectal cancer
NCT00005882 ↗	Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps	Completed	University of California, Irvine	Phase 3	1998-07-01	This randomized phase III trial is studying eflornithine and sulindac to see how well they work compared to a placebo in preventing colorectal cancer in patients with colon polyps. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of eflornithine and sulindac may prevent colorectal cancer. It is not yet known whether eflornithine and sulindac are more effective than a placebo in preventing colorectal cancer
NCT00062023 ↗	Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer	Terminated	National Cancer Institute (NCI)	Phase 2	2003-06-01	RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. It is not yet known whether sulindac, aspirin, or ursodiol is more effective in preventing colorectal cancer. PURPOSE: This randomized phase II trial is studying how well sulindac works compared to aspirin or ursodiol in preventing colorectal cancer.

Clinical Trial Conditions for CLINORIL

Condition Name

Condition Name for CLINORIL
Intervention	Trials
Precancerous Condition	5
Colorectal Cancer	2
Cancer	1
Tobacco Use Disorder	1

Condition MeSH

Condition MeSH for CLINORIL
Intervention	Trials
Precancerous Conditions	5
Colorectal Neoplasms	3
Fibromatosis, Aggressive	1
Adenomatous Polyposis Coli	1

Clinical Trial Locations for CLINORIL

Trials by Country

Trials by Country for CLINORIL
Location	Trials
United States	30
United Kingdom	2
Canada	2
Germany	1
Spain	1

Trials by US State

Trials by US State for CLINORIL
Location	Trials
California	5
Arizona	4
Minnesota	3
Ohio	2
Massachusetts	2

Clinical Trial Progress for CLINORIL

Clinical Trial Phase

Clinical Trial Phase for CLINORIL
Clinical Trial Phase	Trials
Phase 3	3
Phase 2	6

Clinical Trial Status

Clinical Trial Status for CLINORIL
Clinical Trial Phase	Trials
Completed	7
Terminated	1
Unknown status	1

Clinical Trial Sponsors for CLINORIL

Sponsor Name

Sponsor Name for CLINORIL
Sponsor	Trials
National Cancer Institute (NCI)	8
Chao Family Comprehensive Cancer Center	1
University of California, Irvine	1

Sponsor Type

Sponsor Type for CLINORIL
Sponsor	Trials
NIH	8
Other	5
Industry	1